Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.3.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.1.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.2 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.82 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.79.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used